Animal Virus Crosses to Humans: France Records First Human Case of Shuni Virus, Patient Dies

The recording of the first known human infection with the (Shuni) virus in France has reignited debate over the potential risks of the virus, after a patient suffering from severe immune system weakness died. This incident has pushed European and international health authorities to intensify monitoring and studies to understand the nature of the infection and its impact on humans.

According to French authorities, the case was recorded in a patient receiving treatment for a serious illness in the city of Lyon. Initial investigations suggest that the infection was transmitted to him via the bite of a small blood-sucking insect of the (Culicoides) type, which is the same insect known for transmitting the virus among animals.

The Shuni virus is considered one of the viruses that primarily infect livestock and belongs to the same group as the (Schmallenberg) virus, which is associated with disorders affecting animal wealth. It was first discovered in Nigeria in 1965, before being detected later in several countries in Africa and Asia.

During 2026, the virus appeared for the first time in Europe, where it was observed in livestock herds in several countries, including France, Germany, Spain, Ireland, and other European nations. This prompted veterinary authorities to enhance surveillance and monitoring operations.

In animals, the virus can cause fever, diarrhea, and decreased milk production, in addition to abortion and congenital malformations in fetuses in some cases. Neurological disorders have also been observed in some horses.

Although the neurological complications preceding the death of the French patient were likely linked to the virus, health experts emphasize that available data remains limited, especially since the only recorded case involves a person with severe immunodeficiency, making it impossible to generalize results to the rest of the population at this time.

The World Health Organization and the European Centre for Disease Prevention and Control confirmed that there is no evidence of transmission between humans, noting that the probability of widespread viral spread among people remains low according to current data.

As of now, there is no vaccine or specific treatment for the Shuni virus, while medical studies and investigations continue to determine its ability to infect humans and better understand its potential risks.